Skip to Content

T 25 (Tarceva 25 mg)

Generic Name: erlotinib

Pill imprint T 25 has been identified as Tarceva 25 mg.

Tarceva is used in the treatment of non-small cell lung cancer; pancreatic cancer; renal cell carcinoma and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Tarceva 25 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tarceva 25 mg T 25
Tarceva 25 mg T 25
Discount Card Promo
Tarceva
Generic Name:
erlotinib
Imprint:
T 25
Strength:
25 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
EGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Genentech
National Drug Code (NDC):
50242-0062
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5290 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide